1. Home
  2. Browse Decisions
  3. F.3d
  4. 700 F.3d
  5. 700 F.3d 1161 (2012)
 

IN RE LEVAQUIN PRODUCTS LIABILITY LITIGATION

No. 11-3117.

700 F.3d 1161 (2012)

In re LEVAQUIN PRODUCTS LIABILITY LITIGATION. John Schedin, Plaintiff-Appellee v. Ortho-McNeil-Janssen Pharmaceuticals, Inc., Defendant-Appellant.

United States Court of Appeals, Eighth Circuit.

Decided: November 30, 2012.

Attorney(s) appearing for the Case

Charles Lifland , argued, Los Angeles, CA, Tracy Joan Van Steenburgh , Dana M. Lenahan , Minneapolis, MN, John Dames , Chicago, IL, Cynthia Ann Merrill , Los Angeles, CA, on the brief, for appellant.

Charles M. Wolfson , argued, New York, NY, Ronald S. Goldser , Minneapolis, MN, Lewis J. Saul , New York, NY, on the brief, for appellee.

Before RILEY, Chief Judge, BYE and MELLOY, Circuit Judges.

RILEY, Chief Judge.

In 2005, John Schedin suffered Achilles tendon ruptures while taking the drug Levaquin, which Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJP) markets in the United States. Schedin sued OMJP and others for failing to warn adequately of the risk of tendon rupture in patients who, like Schedin, are elderly and taking concomitant corticosteroids. A jury found OMJP primarily liable, awarding Schedin compensatory and punitive damages. OMJP appeals...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases